CC

The Chemours Company

CCBasic MaterialsNASDAQ

Specialty Chemicals

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$5.81B
+0.4% YoY
Net Income
-$386.0M
-659.4% YoY
EBITDA
$332.0M
-49.8% YoY
Free Cash Flow
$303.1M

Scan Results

Daily timeframe
DateIndicatorDetails
Aug 19 MACD Positive CrossoverHistogram +0.1067, positive momentum
Aug 18 MACD Positive CrossoverHistogram +0.0911, positive momentum
About The Chemours Company

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. With a market capitalization of $2.30B, it sits in mid-cap territory. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials.

Where CC stands vs its 150-day and 200-day moving averages

As of the August 19, 2026 close, CC finished 21.37% below its 150-day moving average ($19.61) and 13.08% below its 200-day moving average ($17.74). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is CC overbought or oversold?

At the August 19, 2026 close, CC's RSI(14) was 45.0, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$2.30B
Fwd P/E7.94
EPS$-2.02
Beta1.42
52W Change-8.2%
Dividend Yield2.29%
ROE-319.4%
Analysis

On the balance sheet, CC has $671.0M in cash with $4.12B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $303.1M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of -319.4% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 1.4% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $6.34B (2021) to $5.81B (2025).

The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing CC.

Links
More Basic Materials stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms